Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Preoperative Myocardial Troponin T Elevation is Associated with the Fracture Type in Patients with Proximal Femoral Fracture.

Nordling P, Strandberg M, Strandberg NNG, Kiviniemi TO, Mäkelä KT, Airaksinen KEJ.

Scand J Surg. 2018 Dec 6:1457496918816928. doi: 10.1177/1457496918816928. [Epub ahead of print]

PMID:
30520365
2.

Cardioversion for atrial fibrillation - how to prevent thromboembolic complications?

Jaakkola S, Kiviniemi TO, Airaksinen KEJ.

Ann Med. 2018 Nov;50(7):549-555. doi: 10.1080/07853890.2018.1523552. Epub 2018 Oct 15.

PMID:
30207497
3.

Mobile Phone Detection of Atrial Fibrillation With Mechanocardiography: The MODE-AF Study (Mobile Phone Detection of Atrial Fibrillation).

Jaakkola J, Jaakkola S, Lahdenoja O, Hurnanen T, Koivisto T, Pänkäälä M, Knuutila T, Kiviniemi TO, Vasankari T, Airaksinen KEJ.

Circulation. 2018 Apr 3;137(14):1524-1527. doi: 10.1161/CIRCULATIONAHA.117.032804. Epub 2018 Mar 11. No abstract available.

PMID:
29526834
4.

Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study).

Jaakkola S, Kiviniemi TO, Nuotio I, Hartikainen J, Mustonen P, Palomäki A, Jaakkola J, Ylitalo A, Hartikainen P, Airaksinen KEJ.

Am J Cardiol. 2018 May 15;121(10):1182-1186. doi: 10.1016/j.amjcard.2018.01.038. Epub 2018 Feb 12.

PMID:
29526276
5.

Population trends in mitral valve surgery in Finland between 1997 and 2014: the finnish CVD register.

Myllykangas ME, Aittokallio JM, Pietilä A, Salomaa VV, Gunn JM, Kiviniemi TO, Niiranen TJ.

Scand Cardiovasc J. 2018 Feb;52(1):51-57. doi: 10.1080/14017431.2017.1405068. Epub 2017 Dec 3.

PMID:
29198154
6.

Clinical manifestations and outcomes of severe warfarin overanticoagulation: from the EWA study.

Jaakkola S, Nuotio I, Kiviniemi TO, Virtanen R, Virta A, Airaksinen KEJ.

Ann Med. 2018 Mar;50(2):164-171. doi: 10.1080/07853890.2017.1407494. Epub 2017 Nov 23.

PMID:
29156997
7.

Permanent work disability in patients ≤50 years old after percutaneous coronary intervention and coronary artery bypass grafting (the CRAGS study).

Lautamäki A, Gunn JM, Airaksinen KEJ, Biancari F, Kajander OA, Anttila V, Heikkinen J, Eskola M, Ilveskoski E, Mennander A, Korpilahti K, Wistbacka JO, Kiviniemi TO.

Eur Heart J Qual Care Clin Outcomes. 2017 Apr 1;3(2):101-106. doi: 10.1093/ehjqcco/qcw043.

PMID:
28927176
8.

Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study.

Jaakkola S, Nuotio I, Kiviniemi TO, Virtanen R, Issakoff M, Airaksinen KEJ.

PLoS One. 2017 Apr 20;12(4):e0175975. doi: 10.1371/journal.pone.0175975. eCollection 2017.

9.

Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation.

Varho V, Nammas W, Kiviniemi TO, Sia J, Romppanen H, Pietilä M, Airaksinen JK, Karjalainen PP.

Int J Cardiol. 2017 Jan 15;227:194-200. doi: 10.1016/j.ijcard.2016.11.173. Epub 2016 Nov 9.

PMID:
27839810
10.

Trends in rates, patient selection and prognosis of coronary revascularisations in Finland between 1994 and 2013: the CVDR.

Kiviniemi TO, Pietilä A, Gunn JM, Aittokallio JM, Mähönen MS, Salomaa VV, Niiranen TJ.

EuroIntervention. 2016 Oct 20;12(9):1117-1125. doi: 10.4244/EIJV12I9A183.

11.

Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.

Varho V, Kiviniemi TO, Nammas W, Sia J, Romppanen H, Pietilä M, Airaksinen JK, Mikkelsson J, Tuomainen P, Perälä A, Karjalainen PP.

Int J Cardiovasc Imaging. 2016 Jul;32(7):1031-9. doi: 10.1007/s10554-016-0871-7. Epub 2016 Apr 13.

PMID:
27076220
12.

Occurrence of postpericardiotomy syndrome admissions: A population-based registry study.

Lehto J, Kiviniemi TO, Gunn J, Mustonen P, Airaksinen J, Biancari F, Rautava P, Sipilä J, Kytö V.

Ann Med. 2016;48(1-2):28-33. doi: 10.3109/07853890.2015.1122223. Epub 2015 Dec 15.

PMID:
26671291
13.

Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial.

Lahtela HM, Kiviniemi TO, Puurunen MK, Schlitt A, Rubboli A, Ylitalo A, Valencia J, Lip GY, Airaksinen KE.

PLoS One. 2015 Jun 1;10(6):e0128492. doi: 10.1371/journal.pone.0128492. eCollection 2015.

14.

Transthoracic echocardiography for non-invasive assessment of coronary vasodilator function after DES implantation.

Varho V, Karjalainen PP, Ylitalo A, Airaksinen JK, Mikkelsson J, Sia J, Pietilä M, Kiviniemi TO.

Eur Heart J Cardiovasc Imaging. 2014 Sep;15(9):1029-34. doi: 10.1093/ehjci/jeu059. Epub 2014 Apr 21.

PMID:
24755162
15.

Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.

Karjalainen P, Kiviniemi TO, Lehtinen T, Nammas W, Ylitalo A, Saraste A, Mikkelsson J, Pietila M, Biancari F, Airaksinen JK.

Int J Cardiovasc Imaging. 2013 Dec;29(8):1693-703. doi: 10.1007/s10554-013-0285-8. Epub 2013 Aug 31. Erratum in: Int J Cardiovasc Imaging. 2013 Dec;29(8):1915. Kiviniemi, Tuomas O [added]; Lehtinen, Tuomas [added]; Nammas, Wail [added]; Ylitalo, Antti [added]; Saraste, Antti [added]; Mikkelsson, Jussi [added]; Pietila, Mikko [added]; Biancari, Fausto [added]; Airaksinen, Juhani K E [added].

PMID:
23996244
16.

Vascular healing early after titanium-nitride-oxide-coated stent implantation assessed by optical coherence tomography.

Annala AP, Lehtinen T, Kiviniemi TO, Ylitalo A, Nammas W, Karjalainen PP.

J Invasive Cardiol. 2013 Apr;25(4):186-9.

17.

Early vascular healing after endothelial progenitor cell capturing stent implantation.

Lehtinen T, Kiviniemi TO, Ylitalo A, Mikkelsson J, Airaksinen JK, Karjalainen PP.

J Invasive Cardiol. 2012 Dec;24(12):631-5.

18.

Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes.

Kiviniemi TO, Yegutkin GG, Toikka JO, Paul S, Aittokallio T, Janatuinen T, Knuuti J, Rönnemaa T, Koskenvuo JW, Hartiala JJ, Jalkanen S, Raitakari OT.

Front Physiol. 2012 Aug 23;3:338. doi: 10.3389/fphys.2012.00338. eCollection 2012.

19.

Impaired ATP-induced coronary blood flow and diminished aortic NTPDase activity precede lesion formation in apolipoprotein E-deficient mice.

Mercier N, Kiviniemi TO, Saraste A, Miiluniemi M, Silvola J, Jalkanen S, Yegutkin GG.

Am J Pathol. 2012 Jan;180(1):419-28. doi: 10.1016/j.ajpath.2011.10.002. Epub 2011 Nov 7.

PMID:
22074736
20.

Cold pressor test safety-the incidence of vasovagal reactions.

Kiviniemi TO, Schindler T, Tulppo M, Knuuti J, Raitakari O, Koskenvuo JW.

Am J Cardiol. 2011 Feb 1;107(3):492-3. doi: 10.1016/j.amjcard.2010.10.036. No abstract available.

PMID:
21257022
21.

Cardiopulmonary involvement in Fabry's disease.

Koskenvuo JW, Kantola IM, Nuutila P, Knuuti J, Parkkola R, Mononen I, Hurme S, Kalliokoski R, Viikari JS, Wendelin-Saarenhovi M, Kiviniemi TO, Hartiala JJ.

Acta Cardiol. 2010 Apr;65(2):185-92.

PMID:
20458826
22.

Decreased endothelin-1 levels after acute consumption of red wine and de-alcoholized red wine.

Kiviniemi TO, Saraste A, Lehtimäki T, Toikka JO, Saraste M, Raitakari OT, Hartiala JJ, Viikari J, Koskenvuo JW.

Atherosclerosis. 2010 Jul;211(1):283-6. doi: 10.1016/j.atherosclerosis.2010.01.017. Epub 2010 Jan 25.

PMID:
20137789
23.

Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance.

Koskenvuo JW, Engblom E, Kantola IM, Hartiala JJ, Saraste A, Kiviniemi TO, Mononen I, Saraste M.

Clin Physiol Funct Imaging. 2009 May;29(3):177-80. doi: 10.1111/j.1475-097X.2008.00851.x.

PMID:
19320660
24.

Cardiac magnetic resonance imaging in valvular heart disease.

Koskenvuo JW, Järvinen V, Pärkkä JP, Kiviniemi TO, Hartiala JJ.

Clin Physiol Funct Imaging. 2009 Jul;29(4):229-40. doi: 10.1111/j.1475-097X.2009.00865.x. Epub 2009 Mar 11. Review.

PMID:
19302226
25.

High dose of red wine elicits enhanced inhibition of fibrinolysis.

Kiviniemi TO, Saraste A, Lehtimäki T, Toikka JO, Saraste M, Raitakari OT, Pärkkä JP, Hartiala JJ, Viikari J, Koskenvuo JW.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):161-3. doi: 10.1097/HJR.0b013e328320ad1b.

PMID:
19276983
26.

Effects of cognac on coronary flow reserve and plasma antioxidant status in healthy young men.

Kiviniemi TO, Saraste A, Toikka JO, Saraste M, Raitakari OT, Pärkkä JP, Lehtimäki T, Hartiala JJ, Viikari J, Koskenvuo JW.

Cardiovasc Ultrasound. 2008 Jun 3;6:25. doi: 10.1186/1476-7120-6-25.

27.

A moderate dose of red wine, but not de-alcoholized red wine increases coronary flow reserve.

Kiviniemi TO, Saraste A, Toikka JO, Saraste M, Raitakari OT, Pärkkä JP, Lehtimäki T, Hartiala JJ, Viikari J, Koskenvuo JW.

Atherosclerosis. 2007 Dec;195(2):e176-81. Epub 2007 Jul 26.

PMID:
17662293
28.

Vasodilation of epicardial coronary artery can be measured with transthoracic echocardiography.

Kiviniemi TO, Toikka JO, Koskenvuo JW, Saraste A, Saraste M, Pärkkä JP, Raitakari OT, Hartiala JJ.

Ultrasound Med Biol. 2007 Mar;33(3):362-70.

PMID:
17188799
29.

Comparison of MRI and positron emission tomography for measuring myocardial perfusion reserve in healthy humans.

Pärkkä JP, Niemi P, Saraste A, Koskenvuo JW, Komu M, Oikonen V, Toikka JO, Kiviniemi TO, Knuuti J, Sakuma H, Hartiala JJ.

Magn Reson Med. 2006 Apr;55(4):772-9.

30.

Determinants of coronary flow velocity reserve in healthy young men.

Kiviniemi TO, Snapir A, Saraste M, Toikka JO, Raitakari OT, Ahotupa M, Hartiala JJ, Scheinin M, Koskenvuo JW.

Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H564-9. Epub 2006 Feb 24.

31.

Coronary artery diameter can be assessed reliably with transthoracic echocardiography.

Kiviniemi TO, Saraste M, Koskenvuo JW, Airaksinen KE, Toikka JO, Saraste A, Pärkkä JP, Hartiala JJ.

Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1515-20. Epub 2003 Dec 4.

Supplemental Content

Loading ...
Support Center